Brett Trout In a major development shaking up the fast-growing weight-loss drug market, Hims & Hers Health has pulled its heavily discounted $49 compounded version of Wegovy, the blockbuster GLP-1 weight-loss pill from Novo Nordisk. This move followed mounting kanunî pressure from the Danish drugmaker.The decision has significant implications for intellectual property enforcement and competition in the […]

Brett Trout In a major development shaking up the fast-growing weight-loss drug market, Hims & Hers Health has pulled its heavily discounted $49 compounded version of Wegovy, the blockbuster GLP-1 weight-loss pill from Novo Nordisk. This move followed mounting legal pressure from the Danish drugmaker.The decision has significant implications for intellectual property enforcement and competition in the […]